Teleflex (NYSE: TFX) has purchased hemostatic device developer Z-Medica from healthcare private equity firm Linden Capital. The acquisition adds a portfolio of hemorrhage control dressings comprised of gauze impregnated with kaolin, a clay mineral. Z-Medica’s products address the trauma surgery, EMS, military, emergency department, and interventional segments to complement Teleflex's vascular access system EZ-IO and blood transfusion kit EZPLAZ with similar call-points. Deal terms -- $500m upfront plus up to another $25m in earn-outs.
Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare Mergers, Medical Devices